SPOTLIGHT -
November 19th 2024
As skepticism surrounding AI fades, pharma industry execs are ready to embrace the technology.
November 15th 2024
Ann Beliën, PhD, founder and CEO of Rejuvenate Biomed, discusses how AI is being used to find new ways to treat age-related conditions.
November 14th 2024
Exploring those areas and functions where the application of generative artificial intelligence—through use cases borne out in practice—are demonstrating tangible value and driving life sciences innovation to new heights.
Pleio’s chief experience officer discusses why these platforms are being embraced by the industry.
November 13th 2024
Pharma looks to take advantage of expanded access programs across Asia-Pacific region.
Tackeda Targets Regions with High Unmet Medical Needs with New Access Strategy
August 30, 2016
AstraZeneca Sells Antibiotics Business to Pfizer
August 25, 2016
Global Superbug Response "Needs $5bn Each Year"
Diabetes and Obesity Therapeutics Market to "More Than Double" by 2022
August 24, 2016
Pharma Pursues Innovative Alternatives to Opioids
August 23, 2016
Valeant Appoints Former Zoetis Exec as CFO
Pfizer to Acquire Medivation
FDA Warning Letter to Noven Pharmaceuticals
August 19, 2016
WAVE Life Sciences Recruits Former Shire Exec as CFO
WHO Lists First Diagnostic Test for Zika Virus
Recordati Makes New Appointments Following Death of CEO
August 17, 2016
Turkish Pharma Market Set to Rise by $0.5 Billion by 2020
US CEOs "Upbeat" About Hiring, Industry Prospects
August 16, 2016
Compliance in the 21st Century: A Pharm Exec eBook
Layoffs at Pfizer's Pearl River Plant
August 15, 2016
UK University Looks to Crowdfunding for Cancer Research
EMA Releases Data Integrity Guidance
August 12, 2016
New CEO for Israel's BioLineRx
European Commission Publishes Pharmacovigilance Report
August 11, 2016
Endo Appoints New President of Branded Pharmaceuticals
FDA Approves First Generic Version of Tamiflu
August 09, 2016
New Exec Shake-Up at Valeant
EMA Develops Strategy on Adaptive Pathways
August 05, 2016
NIH Launches Zika Vaccine Clinical Trial
Pfizer Acquires Bamboo Therapeutics
The acquisition will add to the company's cell therapy base and potential impact in treating rare diseases.
New CEO for Inspyr Therapeutics
August 04, 2016
Global Biomarkers Market to Reach "Over $78.2 Billion by 2024"
August 03, 2016
Cannabinoid Medicine Company Names Former Abbott Exec as CEO
UK Researchers Identify 750 Biomarkers for Potential Early Cancer Screening
August 1, 2016
Former Allergan CEO Joins SoCal Startup